BeStock  

Amylyx Pharmaceuticals AMLX

US equityMarket cap rank #2350Drug Manufacturers - Specialty & Generic
$26.02 −$0.18 (-0.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.55 -1.81%
Open$25.64
Prev close$26.20
Day range$25.52 – $26.40
Volume1.14M
Market cap$3.35B
P/E (TTM)–
Dividend yield–

AMLX Stock News

Headlines matching Amylyx Pharmaceuticals or the AMLX ticker, most recent first.

  • Baird Initiates Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Announces Target Price $28Market news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Amylyx Pharmaceuticals(AMLX.US), With a Forecast Between $24 to $34Market news · 7 Aug 2026 · Direct mention
  • Citi Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $26Market news · 4 Aug 2026 · Direct mention
  • Citi Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $26 PositiveMarket news · 3 Aug 2026 · Direct mention
  • Guggenheim Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $57 PositiveMarket news · 27 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $44Market news · 23 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $55Market news · 20 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $42Market news · 20 Aug 2026 · Direct mention
  • TD Cowen Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy RatingMarket news · 19 Aug 2026 · Direct mention
  • Guggenheim Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $55 PositiveMarket news · 19 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Amylyx Pharmaceuticals(AMLX.US), With a Forecast Between $32 to $55Market news · 19 Aug 2026 · Direct mention
  • Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $30 PositiveMarket news · 17 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $24Market news · 30 Jul 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Heart Test Laboratories, Inc. (HSCS) and Align Tech (ALGN)TipRanks · 30 Jul 2026 · Direct mention
  • Mizuho Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Raises Target Price to $24 PositiveMarket news · 20 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on AMLX.

Sign in to join the discussion.

Scroll to Top